Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Sulforaphane is a naturally occurring isothiocyanate found in cruciferous vegetables, particularly broccoli sprouts. Its use in supporting or treating Metabolic Syndrome is supported by emerging scientific evidence, though it remains an area of active research rather than established clinical practice. Metabolic Syndrome is characterized by a cluster of conditions, including insulin resistance, high blood pressure, dyslipidemia, and central obesity. Preclinical studies and limited human trials suggest that sulforaphane may influence several pathways relevant to Metabolic Syndrome. For example, sulforaphane has been shown to activate the Nrf2 pathway, which upregulates antioxidant and cytoprotective genes, potentially reducing oxidative stress and inflammation implicated in metabolic disorders (PubMed 24247452). Small-scale clinical studies have indicated that sulforaphane supplementation can improve fasting glucose and insulin sensitivity in subjects with type 2 diabetes or at risk of metabolic disorders (PubMed 28507254). Additionally, animal studies suggest sulforaphane may reduce hepatic glucose production and improve lipid profiles. However, many of these findings are preliminary, with relatively small sample sizes and short durations. There is not yet robust, large-scale clinical evidence confirming its efficacy for Metabolic Syndrome, so while the scientific basis is promising, the current level of evidence is moderate.

More about Sulforaphane
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by Sulforaphane

Products containing Sulforaphane